1SCHERMULY R T, KREISSELMEIER K P, GHOFRANIH A, et al. Antiremodeling effects of iloprost and the dualelective phosphodiesterase 3/4 inhibitor tolafentrine in chro-nic experimental pulmonary hypertension[J]. Circ Res,2004,94(8) :1101 -1108.
2FOUTY B W, RODMAN D M. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth'musclecells through a p27^Kipl-independent pathway[J]. Circ Res,2003, 92(5) :501-509.
3PAUVERT O, LUGNIER C, KERAVIS T, etal, Effect of sildenafil on cyclic nucleotide phosphodicsterase activity, vascular tone and calcium signaling in rat pulmonary artery[J].Br J Pharmacol, 2003, 139(3) ,513-522.
4MICHELAKIS E D, TYMCHAK W, NOGA M, et al.Long-term treatment with oral sildenafil is safe and improvesfunctional capacity and hemodynamies in patients with pulmo-nary arterial hypertension[J]. Circulation, 2003, 108 (17) :2066-2069.
5ELLIOTT C G, GLISSMEYER E W, HAVLENA G T, etal. Relationship of BMPR2 mutations to vasoreactivity inpulmonary arterial hypertension[J]. Circulation, 2006, 113(21): 2509-2515.
6McMURTRY M S, BONNET S, WU X, etal. Diehloroacetare prevents and reverses pulmonary hypertension hy inducing pulmonary artery smooth muscle cell apoptosis[J]. CircRes, 2004,95(8) :830-840.
7EDDAHIBI S, GUIGNABERT C, BARLiER-MUR A M, etal. Cross talk between endothelial and smooth muscle cells inpulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia[J]. Circulation, 2006,113 (15)1857-1864.
